Diagnostic Products Corp. will acquire the remaining 60percent of its distributor in the United Kingdom, DiagnosticProducts (U.K.) Ltd. The British company will become a whollyowned subsidiary after the transfer.
Diagnostic Products Corp., based in Los Angeles, markets morethan 2,200 different diagnostic kits based on monoclonalantibodies and antigens made by recombinant DNA, said SigiZiering, company chairman. The British unit uses U.S.-mademonoclonals in its manufacturing, which will be consolidatedin a new 100,000-square-foot facility in North Wales.
(c) 1997 American Health Consultants. All rights reserved.